In this video, Motley Fool health care analyst David Williamson takes a look at three biotech stocks making moves today and what you should know about them. Sequenom (NASDAQ: SQNM) made a big jump today despite higher-than-expected losses because of continued interest in its MaterniT21 Down syndrome test. SciClone Pharmaceuticals (NASDAQ:SCLN) released some disappointing numbers. And ISIS Pharmaceuticals (NASDAQ:IONS) is up 15% after a recent buy rec from Cowen, but Williamson warns that there are some mitigating factors around ISIS that should curb investors' enthusiasm.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.